Harnessing the exosome-induced immune response for cancer immunotherapy

Seminars in Cancer Biology

Volumn 28, Issue , 2014, Pages 58-67

  Gehrmann, Ulf ^a   Näslund, Tanja I ^a   Hiltbrunner, Stefanie ^a   Larssen, Pia ^a   Gabrielsson, Susanne ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Adaptive immunity; Cancer immunotherapy; Dendritic cells; Exosomes; Innate immunity

Indexed keywords

GAMMA INTERFERON; NANOPARTICLE; OVALBUMIN;

ACIDIFICATION; ADAPTIVE IMMUNITY; ANTIGEN DETECTION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; BONE MARROW DERIVED DENDRITIC CELL; CANCER IMMUNOTHERAPY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INTERACTION; DENDRITIC CELL; EXOSOME; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSTIMULATION; INNATE IMMUNITY; LUNG LAVAGE; MACROPHAGE; MOLECULAR DYNAMICS; NATURAL KILLER CELL; NONHUMAN; PARTICLE SIZE; PLASMACYTOID DENDRITIC CELL; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; RADIOACTIVITY; REVIEW; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; NEOPLASMS; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PROCEDURES;

ANIMALS; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; DENDRITIC CELLS; EXOSOMES; HUMANS; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; NEOPLASMS;

EID: 84926261192     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2014.05.003     Document Type: Review

References (99)

1. Poschke I., Mougiakakos D., Kiessling R. Camouflage and sabotage: tumor escape from the immune system. Cancer Immunol Immunother 2011, 60(8):1161-1171.
2. Zitvogel L., Apetoh L., Ghiringhelli F., Andre F., Tesniere A., Kroemer G. The anticancer immune response: indispensable for therapeutic success?. J Clin Invest 2008, 118(6):1991-2001.
3. Pulendran B., Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011, 12(6):509-517.
4. Hubert P., Heitzmann A., Viel S., Nicolas A., Sastre-Garau X., Oppezzo P., et al. Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Cancer Res 2011, 71(15):5134-5143.
5. Semmling V., Lukacs-Kornek V., Thaiss C.A., Quast T., Hochheiser K., Panzer U., et al. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs. Nat Immunol 2010, 11(4):313-320.
6. Zitvogel L., Apetoh L., Ghiringhelli F., Kroemer G. Immunological aspects of cancer chemotherapy. Nat Rev Immunol 2008, 8(1):59-73.
7. Raposo G., Nijman H.W., Stoorvogel W., Liejendekker R., Harding C.V., Melief C.J., et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med 1996, 183(3):1161-1172.
8. Colino J., Snapper C.M. Exosomes from bone marrow dendritic cells pulsed with diphtheria toxoid preferentially induce type 1 antigen-specific IgG responses in naive recipients in the absence of free antigen. J Immunol 2006, 177(6):3757-3762.
9. Viaud S., Terme M., Flament C., Taieb J., Andre F., Novault S., et al. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: a role for NKG2D ligands and IL-15Ralpha. PLoS ONE 2009, 4(3):e4942.
10. Zitvogel L., Regnault A., Lozier A., Wolfers J., Flament C., Tenza D., et al. Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes. Nat Med 1998, 4(5):594-600.
11. Escudier B., Dorval T., Chaput N., Andre F., Caby M.P., Novault S., et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med 2005, 3(1):10.
12. Morse M.A., Garst J., Osada T., Khan S., Hobeika A., Clay T.M., et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 2005, 3(1):9.
13. Viaud S., Ploix S., Lapierre V., Thery C., Commere P.H., Tramalloni D., et al. Updated technology to produce highly immunogenic dendritic cell-derived exosomes of clinical grade: a critical role of interferon-gamma. J Immunother 2011, 34(1):65-75.
14. Buschow S.I., van Balkom B.W., Aalberts M., Heck A.J., Wauben M., Stoorvogel W. MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol 2010, 88(8):851-856.
15. Clayton A., Turkes A., Navabi H., Mason M.D., Tabi Z. Induction of heat shock proteins in B-cell exosomes. J Cell Sci 2005, 118(Pt 16):3631-3638.
16. Escola J.M., Kleijmeer M.J., Stoorvogel W., Griffith J.M., Yoshie O., Geuze H.J. Selective enrichment of tetraspan proteins on the internal vesicles of multivesicular endosomes and on exosomes secreted by human B-lymphocytes. J Biol Chem 1998, 273(32):20121-20127.
17. Rialland P., Lankar D., Raposo G., Bonnerot C., Hubert P. BCR-bound antigen is targeted to exosomes in human follicular lymphoma B-cells. Biol Cell 2006, 98(8):491-501.
18. Wubbolts R., Leckie R.S., Veenhuizen P.T., Schwarzmann G., Mobius W., Hoernschemeyer J., et al. Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem 2003, 278(13):10963-10972.
19. Saunderson S.C., Dunn A.C., Crocker P.R., McLellan A.D. CD169 mediates the capture of exosomes in spleen and lymph node. Blood 2014, 123(2):208-216.
20. Papp K., Vegh P., Prechl J., Kerekes K., Kovacs J., Csikos G., et al. B lymphocytes and macrophages release cell membrane deposited C3-fragments on exosomes with T cell response-enhancing capacity. Mol Immunol 2008, 45(8):2343-2351.
21. McLellan A.D. Exosome release by primary B cells. Crit Rev Immunol 2009, 29(3):203-217.
22. Arita S., Baba E., Shibata Y., Niiro H., Shimoda S., Isobe T., et al. B cell activation regulates exosomal HLA production. Eur J Immunol 2008, 38(5):1423-1434.
23. Saunderson S.C., Schuberth P.C., Dunn A.C., Miller L., Hock B.D., MacKay P.A., et al. Induction of exosome release in primary B cells stimulated via CD40 and the IL-4 receptor. J Immunol 2008, 180(12):8146-8152.
24. Muntasell A., Berger A.C., Roche P.A. T cell-induced secretion of MHC class II-peptide complexes on B cell exosomes. EMBO J 2007, 26(19):4263-4272.
25. Vallhov H., Gutzeit C., Johansson S.M., Nagy N., Paul M., Li Q., et al. Exosomes containing glycoprotein 350 released by EBV-transformed B cells selectively target B cells through CD21 and block EBV infection in vitro. J Immunol 2011, 186(1):73-82.
26. Clayton A., Turkes A., Dewitt S., Steadman R., Mason M.D., Hallett M.B. Adhesion and signaling by B cell-derived exosomes: the role of integrins. FASEB J 2004, 18(9):977-979.
27. Pegtel D.M., Cosmopoulos K., Thorley-Lawson D.A., van Eijndhoven M.A., Hopmans E.S., Lindenberg J.L., et al. Functional delivery of viral miRNAs via exosomes. Proc Natl Acad Sci U S A 2010, 107(14):6328-6333.
28. Segura E., Nicco C., Lombard B., Veron P., Raposo G., Batteux F., et al. ICAM-1 on exosomes from mature dendritic cells is critical for efficient naive T-cell priming. Blood 2005, 106(1):216-223.
29. Nolte-'t Hoen E.N., van der Vlist E.J., de Boer-Brouwer M., Arkesteijn G.J., Stoorvogel W., Wauben M.H. Dynamics of dendritic cell-derived vesicles: high-resolution flow cytometric analysis of extracellular vesicle quantity and quality. J Leukocyte Biol 2013, 93(3):395-402.
30. Segura E., Guerin C., Hogg N., Amigorena S., Thery C. CD8+ dendritic cells use LFA-1 to capture MHC-peptide complexes from exosomes in vivo. J Immunol 2007, 179(3):1489-1496.
31. Thery C., Regnault A., Garin J., Wolfers J., Zitvogel L., Ricciardi-Castagnoli P., et al. Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. J Cell Biol 1999, 147(3):599-610.
32. Veron P., Segura E., Sugano G., Amigorena S., Thery C. Accumulation of MFG-E8/lactadherin on exosomes from immature dendritic cells. Blood Cells Mol Dis 2005, 35(2):81-88.
33. Kim S.H., Bianco N.R., Shufesky W.J., Morelli A.E., Robbins P.D. Effective treatment of inflammatory disease models with exosomes derived from dendritic cells genetically modified to express IL-4. J Immunol 2007, 179(4):2242-2249.
34. Thery C., Boussac M., Veron P., Ricciardi-Castagnoli P., Raposo G., Garin J., et al. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 2001, 166(12):7309-7318.
35. Johansson S.M., Admyre C., Scheynius A., Gabrielsson S. Different types of in vitro generated human monocyte-derived dendritic cells release exosomes with distinct phenotypes. Immunology 2008, 123(4):491-499.
36. Kim S.H., Lechman E.R., Bianco N., Menon R., Keravala A., Nash J., et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol 2005, 174(10):6440-6448.
37. Bhatnagar S., Schorey J.S. Exosomes released from infected macrophages contain Mycobacterium avium glycopeptidolipids and are proinflammatory. J Biol Chem 2007, 282(35):25779-25789.
38. Nguyen D.G., Booth A., Gould S.J., Hildreth J.E. Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem 2003, 278(52):52347-52354.
39. Qu Y., Franchi L., Nunez G., Dubyak G.R. Nonclassical IL-1 beta secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J Immunol 2007, 179(3):1913-1925.
40. Qu Y., Ramachandra L., Mohr S., Franchi L., Harding C.V., Nunez G., et al. P2X7 receptor-stimulated secretion of MHC class II-containing exosomes requires the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol 2009, 182(8):5052-5062.
41. Pelchen-Matthews A., Kramer B., Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 2003, 162(3):443-455.
42. Kramer B., Pelchen-Matthews A., Deneka M., Garcia E., Piguet V., Marsh M. HIV interaction with endosomes in macrophages and dendritic cells. Blood Cells Mol Dis 2005, 35(2):136-142.
43. Deneka M., Pelchen-Matthews A., Byland R., Ruiz-Mateos E., Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. J Cell Biol 2007, 177(2):329-341.
44. Chertova E., Chertov O., Coren L.V., Roser J.D., Trubey C.M., Bess J.W., et al. Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J Virol 2006, 80(18):9039-9052.
45. Bhatnagar S., Shinagawa K., Castellino F.J., Schorey J.S. Exosomes released from macrophages infected with intracellular pathogens stimulate a proinflammatory response in vitro and in vivo. Blood 2007, 110(9):3234-3244.
46. Giri P.K., Schorey J.S. Exosomes derived from M. Bovis BCG infected macrophages activate antigen-specific CD4+ and CD8+ T cells in vitro and in vivo. PLoS ONE 2008, 3(6):e2461.
47. Giri P.K., Kruh N.A., Dobos K.M., Schorey J.S. Proteomic analysis identifies highly antigenic proteins in exosomes from M. tuberculosis-infected and culture filtrate protein-treated macrophages. Proteomics 2010, 10(17):3190-3202.
48. Singh P.P., LeMaire C., Tan J.C., Zeng E., Schorey J.S. Exosomes released from M. tuberculosis infected cells can suppress IFN-gamma mediated activation of naive macrophages. PLoS ONE 2011, 6(4):e18564.
49. Anand P.K., Anand E., Bleck C.K., Anes E., Griffiths G. Exosomal Hsp70 induces a pro-inflammatory response to foreign particles including mycobacteria. PLoS ONE 2010, 5(4):e10136.
50. Ramachandra L., Qu Y., Wang Y., Lewis C.J., Cobb B.A., Takatsu K., et al. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation. Infect Immun 2010, 78(12):5116-5125.
51. Quah B.J., O'Neill H.C. Mycoplasma contaminants present in exosome preparations induce polyclonal B cell responses. J Leukocyte Biol 2007, 82(5):1070-1082.
52. Mor-Vaknin N., Punturieri A., Sitwala K., Faulkner N., Legendre M., Khodadoust M.S., et al. The DEK nuclear autoantigen is a secreted chemotactic factor. Mol Cell Biol 2006, 26(24):9484-9496.
53. Hsu D.H., Paz P., Villaflor G., Rivas A., Mehta-Damani A., Angevin E., et al. Exosomes as a tumor vaccine: enhancing potency through direct loading of antigenic peptides. J Immunother 2003, 26(5):440-450.
54. Qazi K.R., Gehrmann U., Domange Jordo E., Karlsson M.C., Gabrielsson S. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood 2009, 113(12):2673-2683.
55. Thery C., Duban L., Segura E., Veron P., Lantz O., Amigorena S. Indirect activation of naive CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol 2002, 3(12):1156-1162.
56. Segura E., Amigorena S., Thery C. Mature dendritic cells secrete exosomes with strong ability to induce antigen-specific effector immune responses. Blood Cells Mol Dis 2005, 35(2):89-93.
57. Naslund T.I., Gehrmann U., Qazi K.R., Karlsson M.C., Gabrielsson S. Dendritic cell-derived exosomes need to activate both T and B cells to induce antitumor immunity. J Immunol 2013, 190(6):2712-2719.
58. Gehrmann U., Hiltbrunner S., Georgoudaki A.M., Karlsson M.C., Naslund T.I., Gabrielsson S. Synergistic induction of adaptive antitumor immunity by codelivery of antigen with alpha-galactosylceramide on exosomes. Cancer Res 2013, 73(13):3865-3876.
59. Prado N., Marazuela E.G., Segura E., Fernandez-Garcia H., Villalba M., Thery C., et al. Exosomes from bronchoalveolar fluid of tolerized mice prevent allergic reaction. J Immunol 2008, 181(2):1519-1525.
60. Aline F., Bout D., Amigorena S., Roingeard P., Dimier-Poisson I. Toxoplasma gondii antigen-pulsed-dendritic cell-derived exosomes induce a protective immune response against T. gondii infection. Infect Immun 2004, 72(7):4127-4137.
61. Beauvillain C., Ruiz S., Guiton R., Bout D., Dimier-Poisson I. A vaccine based on exosomes secreted by a dendritic cell line confers protection against T. gondii infection in syngeneic and allogeneic mice. Microbes Infect 2007, 9(14-15):1614-1622.
62. Morelli A.E., Larregina A.T., Shufesky W.J., Sullivan M.L., Stolz D.B., Papworth G.D., et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 2004, 104(10):3257-3266.
63. Montecalvo A., Shufesky W.J., Stolz D.B., Sullivan M.G., Wang Z., Divito S.J., et al. Exosomes as a short-range mechanism to spread alloantigen between dendritic cells during T cell allorecognition. J Immunol 2008, 180(5):3081-3090.
64. Zhu M., Li Y., Shi J., Feng W., Nie G., Zhao Y. Exosomes as extrapulmonary signaling conveyors for nanoparticle-induced systemic immune activation. Small 2012, 8(3):404-412.
65. Kim S.H., Bianco N., Menon R., Lechman E.R., Shufesky W.J., Morelli A.E., et al. Exosomes derived from genetically modified DC expressing FasL are anti-inflammatory and immunosuppressive. Mol Ther 2006, 13(2):289-300.
66. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur J Immunol 2008, 38(5):1404-1413.
67. Bachmann M.F., Jennings G.T. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 2010, 10(11):787-796.
68. Alvarez-Erviti L., Seow Y., Yin H., Betts C., Lakhal S., Wood M.J. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011, 29(4):341-345.
69. Idoyaga J., Lubkin A., Fiorese C., Lahoud M.H., Caminschi I., Huang Y., et al. Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A. Proc Natl Acad Sci U S A 2011, 108(6):2384-2389.
70. Ding C., Wang L., Marroquin J., Yan J. Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1. Blood 2008, 112(7):2817-2825.
71. Bryniarski K., Ptak W., Jayakumar A., Pullmann K., Caplan M.J., Chairoungdua A., et al. Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity. J Allergy Clin Immunol 2013, 132(1):170-181.
72. Bonifaz L.C., Bonnyay D.P., Charalambous A., Darguste D.I., Fujii S., Soares H., et al. In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 2004, 199(6):815-824.
73. Ruiss R., Jochum S., Mocikat R., Hammerschmidt W., Zeidler R. EBV-gp350 confers B-cell tropism to tailored exosomes and is a neo-antigen in normal and malignant B cells - a new option for the treatment of B-CLL. PLoS ONE 2011, 6(10):e25294.
74. Esser J., Gehrmann U., D'Alexandri F.L., Hidalgo-Estevez A.M., Wheelock C.E., Scheynius A., et al. Exosomes from human macrophages and dendritic cells contain enzymes for leukotriene biosynthesis and promote granulocyte migration. J Allergy Clin Immunol 2010, 126(5):1032-1040. 40 e1-4.
75. Subra C., Grand D., Laulagnier K., Stella A., Lambeau G., Paillasse M., et al. Exosomes account for vesicle-mediated transcellular transport of activatable phospholipases and prostaglandins. J Lipid Res 2010, 51(8):2105-2120.
76. Sala A., Folco G., Murphy R.C. Transcellular biosynthesis of eicosanoids. Pharmacol Rep 2010, 62(3):503-510.
77. Torregrosa Paredes P., Esser J., Admyre C., Nord M., Rahman Q.K., Lukic A., et al. Bronchoalveolar lavage fluid exosomes contribute to cytokine and leukotriene production in allergic asthma. Allergy 2012, 67(7):911-919.
78. Andre F., Chaput N., Schartz N.E., Flament C., Aubert N., Bernard J., et al. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells. J Immunol 2004, 172(4):2126-2136.
79. Singh P.P., Smith V.L., Karakousis P.C., Schorey J.S. Exosomes isolated from mycobacteria-infected mice or cultured macrophages can recruit and activate immune cells in vitro and in vivo. J Immunol 2012, 189(2):777-785.
80. Simhadri V.R., Reiners K.S., Hansen H.P., Topolar D., Simhadri V.L., Nohroudi K., et al. Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS ONE 2008, 3(10):e3377.
81. Reiners K.S., Topolar D., Henke A., Simhadri V.R., Kessler J., Sauer M., et al. Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity. Blood 2013, 121(18):3658-3665.
82. Hedlund M., Nagaeva O., Kargl D., Baranov V., Mincheva-Nilsson L. Thermal- and oxidative stress causes enhanced release of NKG2D ligand-bearing immunosuppressive exosomes in leukemia/lymphoma T and B cells. PLoS ONE 2011, 6(2):e16899.
83. Hedlund M., Stenqvist A.C., Nagaeva O., Kjellberg L., Wulff M., Baranov V., et al. Human placenta expresses and secretes NKG2D ligands via exosomes that down-modulate the cognate receptor expression: evidence for immunosuppressive function. J Immunol 2009, 183(1):340-351.
84. Mincheva-Nilsson L., Nagaeva O., Chen T., Stendahl U., Antsiferova J., Mogren I., et al. Placenta-derived soluble MHC class I chain-related molecules down-regulate NKG2D receptor on peripheral blood mononuclear cells during human pregnancy: a possible novel immune escape mechanism for fetal survival. J Immunol 2006, 176(6):3585-3592.
85. Lamparski H.G., Metha-Damani A., Yao J.Y., Patel S., Hsu D.H., Ruegg C., et al. Production and characterization of clinical grade exosomes derived from dendritic cells. J Immunol Methods 2002, 270(2):211-226.
86. Coppieters K., Barral A.M., Juedes A., Wolfe T., Rodrigo E., Thery C., et al. No significant CTL cross-priming by dendritic cell-derived exosomes during murine lymphocytic choriomeningitis virus infection. J Immunol 2009, 182(4):2213-2220.
87. Hao S., Bai O., Yuan J., Qureshi M., Xiang J. Dendritic cell-derived exosomes stimulate stronger CD8+ CTL responses and antitumor immunity than tumor cell-derived exosomes. Cell Mol Immunol 2006, 3(3):205-211.
88. Hao S., Bai O., Li F., Yuan J., Laferte S., Xiang J. Mature dendritic cells pulsed with exosomes stimulate efficient cytotoxic T-lymphocyte responses and antitumour immunity. Immunology 2007, 120(1):90-102.
89. Chaput N., Schartz N.E., Andre F., Taieb J., Novault S., Bonnaventure P., et al. Exosomes as potent cell-free peptide-based vaccine. II. Exosomes in CpG adjuvants efficiently prime naive Tc1 lymphocytes leading to tumor rejection. J Immunol 2004, 172(4):2137-2146.
90. Admyre C., Bohle B., Johansson S.M., Focke-Tejkl M., Valenta R., Scheynius A., et al. B cell-derived exosomes can present allergen peptides and activate allergen-specific T cells to proliferate and produce TH2-like cytokines. J Allergy Clin Immunol 2007, 120(6):1418-1424.
91. Peche H., Heslan M., Usal C., Amigorena S., Cuturi M.C. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection. Transplantation 2003, 76(10):1503-1510.
92. Prado N., Canamero M., Villalba M., Rodriguez R., Batanero E. Bystander suppression to unrelated allergen sensitization through intranasal administration of tolerogenic exosomes in mouse. Mol Immunol 2010, 47(11-12):2148-2151.
93. Hugues S., Scholer A., Boissonnas A., Nussbaum A., Combadiere C., Amigorena S., et al. Dynamic imaging of chemokine-dependent CD8+ T cell help for CD8+ T cell responses. Nat Immunol 2007, 8(9):921-930.
94. Hivroz C., Chemin K., Tourret M., Bohineust A. Crosstalk between T lymphocytes and dendritic cells. Crit Rev Immunol 2012, 32(2):139-155.
95. Ridge J.P., Di Rosa F., Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature 1998, 393(6684):474-478.
96. Cinamon G., Zachariah M.A., Lam O.M., Foss F.W., Cyster J.G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat Immunol 2008, 9(1):54-62.
97. Blanc L., Barres C., Bette-Bobillo P., Vidal M. Reticulocyte-secreted exosomes bind natural IgM antibodies: involvement of a ROS-activatable endosomal phospholipase iPLA2. Blood 2007, 110(9):3407-3416.
98. Link A., Zabel F., Schnetzler Y., Titz A., Brombacher F., Bachmann M.F. Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J Immunol 2012, 188(8):3724-3733.
99. Denzer K., van Eijk M., Kleijmeer M.J., Jakobson E., de Groot C., Geuze H.J. Follicular dendritic cells carry MHC class II-expressing microvesicles at their surface. J Immunol 2000, 165(3):1259-1265.